Results 21 to 30 of about 18,563 (231)

Pseudomyxoma Peritonei Secondary to Rupture of Intraductal Papillary Neoplasm of Pancreas (IPMN) [PDF]

Journal of Clinical and Diagnostic Research, 2018
Pseudomyxoma peritonei is the intraperitoneal accumulation of a gelatinous ascites secondary to mucinous tumour rupture, more commonly associated with ovarian and appendiceal mucinous tumour.
Saurabh Kumar, Alok Kumar mittal
doaj   +1 more source

The Cancer Diaspora: A Rare Case of Pseudomyxoma Peritonei of Appendiceal Origin

Journal of Investigative Medicine High Impact Case Reports, 2023
Pseudomyxoma peritonei (PMP) is a rare clinical entity characterized by widespread mucinous implants in the peritoneal cavity. Commonly seen in females in their 50s, PMP typically originates from ruptured appendiceal mucoceles that find refuge in the ...
Lefika Bathobakae MD, MPH, Sacide S. Ozgur MD, Mohita Jariwala BA, Jaydev Kesrani MD, Shajla Ajas MD, Mehandar Kumar MD, Amer Akmal MD   +6 more
doaj   +1 more source

BEV-IP : perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis [PDF]

, 2015
Background: Selected patients with peritoneal carcinomatosis (PC) from colorectal cancer (CRC) benefit from cytoreductive surgery (CRS) combined with intraperitoneal chemoperfusion (IPC).
Ceelen, Wim, Liberale, Gabriel, Van Der Speeten, Kurt, Willaert, Wouter   +3 more
core   +4 more sources

Pseudomyxoma peritonei originating from small intestine: A case report and review of literature. [PDF]

World J Clin Oncol
Shi GJ, Wang C, Zhang P, Lu YY, Zhou HP, Ma RQ, An LB.   +6 more
europepmc   +2 more sources

Diagnostic and Therapeutic Algorithm for Appendiceal Tumors and Pseudomyxoma Peritonei: A Consensus of the Peritoneal Malignancies Oncoteam of the Italian Society of Surgical Oncology (SICO) [PDF]

, 2023
Aim: Pseudomyxoma peritonei (PMP) is an uncommon pathology, and its rarity causes a lack of scientific evidence, precluding the design of a prospective trial.
Berchialla, Paola
core   +5 more sources

Cytoreduction and Hyperthermic Intrathoracic Chemotherapy for Metastatic Pseudomyxoma Peritonei. [PDF]

Ann Thorac Surg Short Rep
Pleural extension of pseudomyxoma peritonei is rare, and treatment demands multidisciplinary care. Perioperative management during cytoreductive surgery and hyperthermic intrathoracic chemotherapy challenges anesthesiology and surgical teams in unique ...
Matzek LJ, Otta JJ, Hofer RE, Sims CR, Kerfeld MJ, Stewart TM, Grotz TE, Tapias LF.   +7 more
europepmc   +2 more sources

Prognostic factors influencing infectious complications after cytoreductive surgery and HIPEC. Results from a tertiary referral center [PDF]

, 2019
Background. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) showed promising results in selected patients. High morbidity restrains its wide application.
Carbonari, Ludovica, Cardi, Maurizio, D'Agostino, Claudia, Fonsi, Giovanni Battista, Francesco Di Marzo,, Francesco, Lefoche, LA TORRE, Giuseppe, Sammartino, Paolo, Sibio, Simone   +8 more
core   +1 more source

Appendiceal mucocele with pseudomyxoma peritonei mimicking ovarian tumor with peritoneal carcinomatosis

Radiology Case Reports, 2022
Appendiceal mucocele with unprompted pseudomyxoma peritonei is a rare malignant tumor, which is difficult to diagnose before surgery. We present a case of a 62-year-old woman, and subsequently discuss the clinical and imaging presentation of mucoceles ...
Chirihan Ayadi, Amine Naggar, Hajar Andour, Fatima zahrae Chraa, Hounayda Jerguigue, Rachida Latib, Youssef Omor   +6 more
doaj   +1 more source

Intraperitoneal chemotherapy for peritoneal metastases : an expert opinion

, 2020
Introduction: The rationale for intraperitoneal (IP) drug delivery for patients with peritoneal metastases (PM) is based on the pharmacokinetic advantage resulting from the peritoneal-plasma barrier, and on the potential to adequately treat small, poorly
Braet, Helena, Ceelen, Wim, Remaut, Katrien, Van Ramshorst, Gabrielle, Willaert, Wouter   +4 more
core   +1 more source

Transfusion of stored autologous blood in patients with low-grade pseudomyxoma peritonei: A retrospective analysis of its safety and outcome

Frontiers in Oncology, 2022
BackgroundPseudomyxoma peritonei is a rare disease that presents as a malignant tumor on the peritoneal surface. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy is the standard treatment for this disease and frequently ...
Xiaoyun Gao, Liduo Kou, Hang Guan, Hua Tian, Junhui Jia, Yu Bai, Wei Bai, Yanhui Di, Ruiqing Ma, Xinhua Wang   +9 more
doaj   +1 more source